A Clinical Study Evaluating the Pharmacokinetics and Pharmacodynamics of HSK39004 Inhalation Suspension in COPD Patients

NCT07331402 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

COPD Patients

Interventions

DRUG: HSK39004 inhalation suspension

Sponsor

Haisco Pharmaceutical Group Co., Ltd.